天下无双

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

可凡倾听

一 | (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed. China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval. A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country. Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category. This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading. At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly. To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong. The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions. In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total. (By Tang Yuxian) 。 CHICAGO -- A teenager who was shot and wounded during a 2019 shootout between suburban Chicago police and a bank robbery suspect inside a music school has reached a $1.9 million settlement with the city of Des Plaines.Rylan Wilder signed off this week on the settlement, nearly four years after a bullet fired by Des Plaines Officer James Armstrong tore a hole through his left arm, the Chicago Sun-Times reported.Armstrong was chasing an armed man who had shot another officer after a bank robbery in Des Plaines when the suspect ran into Upbeat Music & Arts on Chicago’s Northwest Side. Armstrong followed him inside, shooting and killing him. In the process, he also accidentally shot Wilder, who was 15 and working as an intern at the school.The bullet that hit the crook of Wilder's left elbow destroyed an artery, shredded a nerve and obliterated bone, threatening his guitar-playing dreams.Wilder's parents sued in Cook County circuit court, alleging that the officer's actions were excessive and that he displayed “reckless, willful and wanton conduct.” Armstrong wasn’t criminally charged in the shooting, was cleared of wrongdoing by the city, and is still with the department.Wilder, who's now 19 and a sophomore at Columbia College Chicago, needed more than a dozen operations and three years of physical therapy. He said he’s still playing guitar and writing music; he recently produced a song for his girlfriend. But he still suffers from his wound.“My whole arm still feels very numb. I can’t feel in most of my fingers or in my hand," Wilder told the Chicago Sun-Times Wednesday at his attorney’s office.Under the settlement with Des Plaines, the city doesn't admit wrongdoing or liability, according to a statement it released.。